Winthrop Capital Management, LLC Sarepta Therapeutics, Inc. Transaction History
Winthrop Capital Management, LLC
- $364 Million
- Q1 2025
A detailed history of Winthrop Capital Management, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Winthrop Capital Management, LLC holds 9 shares of SRPT stock, worth $155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9
Previous 21
57.14%
Holding current value
$155
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
508Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$178 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$156 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$156 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$70.1 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$58 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.51B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...